Fastbase Solutions has developed a high specificity, super-sensitive, quantitative biomarker platform employing amplified FRET. This platform is designed to report on protein activation states and protein-complex formation in situ, such as in tumor biopsies. The mission of Fastbase Solutions is to be the leading platform in cancer diagnostics, bringing precision to cancer patient treatment.


Request More Information

Name *